CIDRAP newsletters options
Agencies didn't perform in the roles identified for the emergency return of US citizens, the GAO says.
Also, NIH will fund a trial to test several existing medications for people to self-administer to treat COVID-19.
An analysis of extracorporeal membrane oxygenation (ECMO) use at 17 intensive care units (ICUs) in the greater Paris area during France's first COVID-19 wave reveal that 90-day survival was strongly linked to a hospital's earlier experience with the procedure. Investigators from France detailed their findings yesterday in The Lancet Respiratory Medicine.
CARB-X announced today that it is awarding Durham, North Carolina, biotech company Baebies Inc. up to $3.9 million to develop a rapid, easy-to-use diagnostic test for sepsis in newborns.
With thousands of new places to get a vaccine, 9 of 10 Americans live within 5 miles of an immunization site.
Brain abnormalities could explain the confusion and delirium of severe COVID-19.
"Big numbers can make us numb. But each one of these deaths is a tragedy for families, communities, and nations."
CARB-X announced today that it is awarding Phico Therapeutics of Cambridge, United Kingdom, up to $5.3 million to develop an intravenous bacteriophage drug to treat ventilator-associated pneumonia caused by Pseudomonas aeruginosa.
A study in an Atlanta school district revealed that the highest secondary COVID-19 attack rates were in indoor, high-contact sports settings (23.8%), staff meetings or lunches (18.2%), and elementary school classrooms (9.5%), and that staff were more susceptible to COVID-19 than students were.
Slavitt said vaccination is still the main tool to end the pandemic, and he encouraged all Americans to get the vaccine next week, when eligibility expands.
Artemisinin-based treatment remains highly effective, but resistance mutations and delayed parasite clearance were found.
Should studies show COVID-19 effectiveness, fluvoxamine's supply chain looks resilient, an expert says.
Even countries that managed earlier outbreaks well face surges, and officials say they're tracking the variant fueling India's rise.
In-hospital COVID death rates are declining, but the virus still poses substantial risk, including a doubled death rate in surgical patients.
Secondary analysis of patients from a postdischarge decolonization trial of methicillin-resistant Staphylococcus aureus (MRSA) carriers found that re-hospitalization for MRSA was associated with extensive exposure to non-MRSA antibiotics and Clostridioides difficile infection (CDI), researchers reported today in Infection Control & Hospital Epidemiology.
UK researchers have uncovered the novel mechanism behind rare abnormal blood clotting seen in some AstraZeneca/Oxford vaccine recipients, according to a study today in the New England Journal of Medicine.
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
"This has put Brazil in a permanent state of mourning and led to the near collapse of Brazil's health system."
Only 2 of the 11 antibiotics approved since 2017 represent a novel class, and the pipeline is insufficient to counter rising resistance, experts say.
COVID-19 poses 8 to 10 times the risk of blood clots in the brain than do COVID vaccines, a preprint study finds.
